Efroze Chemical Industries
Efroze Chemical Industries is a Pakistan-based, family-controlled pharmaceutical manufacturer founded in 1968 that produces over 40 generic pharmaceutical products across cardiology, gynecology, pain management, and other therapeutic categories for domestic distribution and export to 22+ countries.
- Company typePrivate
- Founded1968
- HeadquartersKarachi, Pakistan
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Efroze Chemical Industries does
Efroze Chemical Industries (Private) Ltd. is a Pakistan-based, family-controlled pharmaceutical manufacturer founded in 1968 and headquartered in Karachi. The company manufactures and markets a diversified portfolio of over 40 pharmaceutical products spanning cardiology, orthopedics and pain management, gynecology and women's health, gastroenterology, anti-infectives, respiratory, anti-diabetic, and anti-malarial therapeutic categories. Manufacturing is conducted at a single GMP-compliant facility in the Korangi Industrial Area (established 1973), supported by an advanced quality control laboratory (ISO 17025 certified), a specialized hormone production line, and a product development department operating to ICH stability guidelines. The portfolio spans tablets, capsules, liquid syrups/suspensions, dry powder sachets, and specialty hormone products.
Efroze's go-to-market operates through two channels. Domestically, the company reaches more than 40,000 pharmacies, hospitals, and clinics across Pakistan via a network of over 70 pharmaceutical distributors compliant with cGDP/cGSP standards, supported by a medical representative force and continuous medical education programs. Internationally, the company maintains an active presence in 22+ countries across South Asia, Southeast Asia, Central Asia, the Middle East, and Africa, with over 150 product registrations in 15 countries. International operations are managed through a Representative Office in Uzbekistan for the CIS region and a joint venture with HOMI in Sudan for African market expansion.
Revenue is generated through one-time product sales across domestic distribution and international exports, with no disclosed subscription or licensing model. The company holds ISO 9001:2015, 14001:2015, and 45001:2015 certifications, was the only Pakistani pharmaceutical company to receive three consecutive Government of Pakistan Export Merit Trophies (2005–2007), and has its Mefnac brand ranked among the top 10 pharmaceutical brands in Sudan. Ownership and senior leadership are concentrated within the Feroz family across Managing Director, Deputy Managing Director, and Director-level positions covering marketing, finance, operations, and HR.
Efroze Chemical Industries firmographics
Firmographics- Name
- Efroze Chemical Industries
- Legal name
- Efroze Chemicals Industries (Private) Ltd.
- Website
- https://efroze.com
- Company type
- Private
- Founded year
- 1968
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Efroze Chemical Industries is a Pakistan-based, family-controlled pharmaceutical manufacturer founded in 1968 that produces over 40 generic pharmaceutical products across cardiology, gynecology, pain management, and other therapeutic categories for domestic distribution and export to 22+ countries.
- Ownership category
- akta.pro rank
Efroze Chemical Industries industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
- akta.pro secondary industries
- Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE), Women’s Health & Reproductive Specialty Pharmaceuticals (HLAIACAN)
Keywords
Where Efroze Chemical Industries is headquartered
LocationHeadquarters
- HQ city
- Karachi
- HQ country
- Pakistan
- HQ region
- Asia
Offices3 records
Markets served
Efroze Chemical Industries business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Pharmaceutical Product Sales: Manufacturing and sale of quality pharmaceutical products including analgesics, antibiotics, anti-hypertensives, anti-diabetics, hormones, and other therapeutic categories. Products sold through distribution network of over 70 distributors covering 40,000+ pharmacies in Pakistan and registered in 15+ countries internationally.
- International Exports: Export of pharmaceutical products to over 22 countries globally including Afghanistan, Bangladesh, Belarus, Cambodia, Ghana, Kenya, Kyrgyzstan, Maldives, Myanmar, Nigeria, Senegal, Singapore, South Sudan, Sri Lanka, Sudan, Uzbekistan, Vietnam. Recognized with 3 consecutive Export Merit Trophies for 2005, 2006, 2007.
Go-to-market motion3 records
Distribution channels1 record
Marketing channels4 records
Efroze Chemical Industries product offering
Product offeringCore offering
Efroze Chemical Industries manufactures and markets a diversified portfolio of over 40 branded pharmaceutical products in solid and liquid dosage forms (tablets, capsules, syrups, suspensions, dry powders, and specialty hormone products). The company's product range spans cardiology, orthopedics/pain management, gynecology, gastroenterology, anti-infectives, respiratory, anti-diabetic, and anti-malarial therapeutic categories, sold domestically through 70+ distributors covering 40,000+ pharmacies in Pakistan and exported to 22+ countries worldwide.
Product overview
Efroze Chemical Industries (Private) Ltd. is a Pakistani pharmaceutical company established in 1968, dedicated to manufacturing quality pharmaceuticals. The company operates a diversified portfolio of over 40 pharmaceutical products spanning multiple therapeutic segments including Cardiology (Corbis, Corbis-H, Valcard), Orthopedics/Pain Management (Algaphan, Algaphan Forte, Kontab, Tramapar, Tramajet, Tramajet SR, Pefree), Gynecology (Efotrel, Eforeth-N, Gynaecosid, Gestatron, Femiroz), Gastroenterology (Efome, Efrozole, Emod, Trisil, Trisil Plus, Trisil D, Panaram), Anti-Infectives (Floxer, Roxin, Klabid, Erizole), Respiratory (Montef, Deslet, Zetrine), Anti-Diabetic (Glicon, Metphage, Metcon Plus), and Anti-Malarial (Maladar). The company also produces lipid-lowering agents (Savuros), NSAID products (Mefnac, Mefnac DS, Pango), and operates a specialized Hormone Section for specialty hormone products. Manufacturing capabilities include solid and liquid dosage forms (tablets, capsules, syrups/suspensions, dry powders) with both domestic marketing across Pakistan and international presence in 15+ countries.
Differentiator
Problem solved
Functional benefit
Products and services
- Algaphan Anti-Spasmodic Muscle Relaxant tablets containing Paracetamol + Orphenadrine Citrate for muscle spasm, strains, sprains, headache, backache, and related pain conditions.
- Algaphan Forte Analgesic Muscle Relaxant tablets containing 650mg Paracetamol + 50mg Orphenadrine Citrate for muscle spasm, strains, sprains, headache, backache, neuralgia, rheumatic pain, and fever.
- Corbis Anti-Hypertensive tablets containing Bisoprolol Fumarate (2.5mg/5mg/10mg) for treatment of hypertension and cardiovascular conditions.
- Corbis-H Anti-Hypertensive combination tablets containing Bisoprolol Fumarate + Hydrochlorothiazide for hypertension, coronary heart disease, cardiac arrhythmias, and ischemic heart diseases.
- Deslet Non-Sedating Anti-Allergic tablets/syrup containing Desloratadine for treatment of seasonal allergic rhinitis and urticaria.
- Efotrel Female Hormone tablets containing Levonorgestrel for contraceptive and hormonal applications.
- Eforeth-N Female Hormone tablets containing Norethisterone (5mg) for treatment of metropathia haemorrhagica, premenstrual syndrome, endometriosis, menorrhagia, and dysmenorrhoea.
- Efome Proton Pump Inhibitor capsules containing Omeprazole (20mg, 40mg) for treatment of peptic ulcers, heartburn, GERD, and conditions with excessive stomach acid.
- Efrozole Proton Pump Inhibitor capsules containing Esomeprazole (20mg, 40mg) for treatment of peptic ulcers, heartburn, GERD, and conditions with excessive stomach acid.
- Emod Anti-Diarrhoeal capsules containing Loperamide HCl (2mg) for symptomatic control of acute and chronic diarrhea.
- Erizole Broad Spectrum Anthelmintic suspension/tablet containing Mebendazole for treatment of pinworm, whipworm, roundworm, and hookworm infections.
- Femiroz Anti-Emetic tablets containing Doxylamine Succinate + Pyridoxine HCl for relief of nausea-vomiting in pregnancy.
- https://efroze.com/wp-content/uploads/2025/08/Floxer-Tab-250-500-1.jpg Broad-Spectrum Quinolone Antibiotic tablets containing Levofloxacin for treatment of pharyngitis, sinusitis, bronchitis, pneumonia, and skin infections.
- https://efroze.com/wp-content/uploads/2022/03/Glicon.png Anti-Diabetic tablets containing Glibenclamide (5mg) for treatment of type II Diabetes Mellitus.
- https://efroze.com/wp-content/uploads/2025/08/Gynaecosid-Tablet-3.jpg Female hormone tablets containing Methylestradiol + Methylestrenolone for treatment of secondary amenorrhea.
- https://efroze.com/wp-content/uploads/2025/10/Gestatron.jpg Female Hormone tablets containing Dydrogesterone (10mg) for irregular menstrual cycle, endometriosis, dysmenorrhea, infertility, dysfunctional uterine bleeding, and HRT.
- https://efroze.com/wp-content/uploads/2025/10/Kontab-Tablet-1.jpg Anti-Inflammatory Enzyme Preparation tablets containing Bromelain + Trypsin for treatment of inflammatory pains, soft tissue inflammation, and edema associated with trauma and surgery.
- https://efroze.com/wp-content/uploads/2025/08/Klabid-250-500-1.jpg Macrolide Antibiotic tablets containing Clarithromycin for treatment of respiratory tract infections, pharyngitis, sinusitis, bronchitis, pneumonia, and skin infections.
- https://efroze.com/wp-content/uploads/2025/11/Mefnac-Tablet-Suspension.jpg NSAID tablets/suspension containing Mefenamic Acid for treatment of pain, fever, and abdominal cramps associated with menstrual cycle.
- https://efroze.com/wp-content/uploads/2025/08/Mefnac-DS-Tablet-2.jpg NSAID high-strength tablets containing Mefenamic Acid (500mg) for treatment of fever.
- https://efroze.com/wp-content/uploads/2025/11/Metcon-Plus.jpg Oral Antidiabetic Agent tablets containing Metformin HCl + Glibenclamide for improved glycemic control in type 2 diabetes patients.
- https://efroze.com/wp-content/uploads/2022/03/Metphage.png Anti-Diabetic tablets containing Metformin HCl (500mg) for treatment of Type II Diabetes Mellitus.
- https://efroze.com/wp-content/uploads/2025/08/Montef-tablet-5-10-2.jpg Antiasthmatic tablets containing Montelukast Sodium (4mg, 5mg, 10mg) for chronic treatment and prophylaxis of asthma for adults and pediatric patients.
- https://efroze.com/wp-content/uploads/2025/11/Maladar-Tablet-Suspension.jpg Anti-Malarial tablets/suspension containing Sulfadoxine + Pyrimethamine for prophylaxis and treatment of malaria.
- https://efroze.com/wp-content/uploads/2025/11/Panaram-Suspension-Tablets.jpg Analgesic & Antipyretic tablets/suspension containing Paracetamol for treatment of pain and fever.
- https://efroze.com/wp-content/uploads/2025/08/Pango-120ml-1.jpg NSAID suspension containing Ibuprofen (100mg/5ml) for treatment of mild to moderate pain and fever.
- https://efroze.com/wp-content/uploads/2025/09/Pefree-2.jpg Analgesic & Anti-Inflammatory tablets containing Aceclofenac for relief of pain and inflammation in osteoarthritis, autoimmune diseases, and ankylosing spondylitis.
- https://efroze.com/wp-content/uploads/2025/08/Roxin-250-500-1.jpg Antibacterial Quinolone tablets containing Ciprofloxacin (250mg, 500mg) for treatment of severe systemic bacterial infections.
- https://efroze.com/wp-content/uploads/2025/08/Seloxx-Cap-100-200-1.jpg Anti-Inflammatory capsules containing Celecoxib (100mg/200mg) for symptomatic treatment of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
- https://efroze.com/wp-content/uploads/2022/03/1-min-1-2-3-4-5-6-7-8-9.png Lipid lowering Agent tablets containing Rosuvastatin (5mg, 10mg, 20mg) to reduce elevated cholesterol, LDL-C, APO B, triglycerides and increase HDL-C in hyperlipidemia patients.
- https://efroze.com/wp-content/uploads/2025/11/Siam-Tablet-and-Susp-1.jpg Antacids tablets/suspension containing Aluminium Hydroxide + Magnesium Hydroxide + Simethicone for symptomatic relief of gastric discomfort.
- https://efroze.com/wp-content/uploads/2025/08/Tramajet-Tab-2.jpg Analgesic capsules containing Tramadol Hydrochloride (100mg) for moderate to severe pain management.
- https://efroze.com/wp-content/uploads/2025/11/Tramajet-SR-1.jpg Sustained release analgesic tablets containing Tramadol Hydrochloride for extended pain management.
- https://efroze.com/wp-content/uploads/2025/08/Tramapar-Tab-1.jpg Centrally Acting Analgesic tablets containing Tramadol HCl + Paracetamol (37.5mg + 325mg) for mild to moderate acute and chronic rheumatic pains.
- https://efroze.com/wp-content/uploads/2025/08/Trisil-200-Tablets-2.jpg Antacid tablets containing Aluminium Hydroxide + Magnesium Trisilicate for symptomatic relief of gastric discomfort, peptic ulcer, esophagitis, and heartburn.
- https://efroze.com/wp-content/uploads/2025/08/Trisil-Plus-Tablet-Suspension-2.jpg Antacids tablets/suspension containing Aluminium Hydroxide + Magnesium Hydroxide + Simethicone for symptomatic relief of gastric discomfort and colic pain.
- https://efroze.com/wp-content/uploads/2025/11/Trisil-D-Oral-Suspension.jpg Antacid oral suspension containing Dicyclomine Hydrochloride + Dried Aluminium Hydroxide Gel + Light Magnesium Oxide + Simethicone for gastric discomfort relief.
- https://efroze.com/wp-content/uploads/2022/10/VCalcard-e1664956845327.jpg Anti-Hypertensive tablets containing Amlodipine + Valsartan for treatment of essential hypertension.
- https://efroze.com/wp-content/uploads/2025/09/zetrine-2-300x122-1.png Non-Sedating Anti-Allergic syrup containing Cetirizine 2HCI for treatment of allergic conditions.
Quantifiable outcome
- Top 10 pharmaceutical brand in Sudan - Mefnac
- +1 more outcomes
Companies that use Efroze Chemical Industries
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles2 records
Efroze Chemical Industries technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Efroze Chemical Industries partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- HOMI, SudanminorJoint venture agreement signed in 2005 with HOMI in Sudan for pharmaceutical operations and market expansion in the African region.
Scale indicators6 records
Recent moves12 records
Expansion highlights4 records
Efroze Chemical Industries competitors and assessment
Company assessmentDirect peers
- Ferozsons Laboratories: Ferozsons Laboratories is a Pakistani pharmaceutical manufacturer with branded generics and licensing partnerships across multiple therapeutic areas including hepatitis and oncology — comparable to Efroze in domestic market positioning and international expansion model.
- Hilton Pharma: Hilton Pharma is a Pakistani pharmaceutical manufacturer with a diversified branded generics portfolio across multiple therapeutic categories, comparable to Efroze in scale, product breadth, and domestic distribution approach.
- Searle Pakistan: Searle Pakistan manufactures and markets branded pharmaceutical products across cardiology, women's health, and general medicine with an established distribution network in Pakistan and selective international presence — directly comparable in therapeutic mix and domestic channel strength.
- Barrett Hodgson Pakistan: Barrett Hodgson is a Pakistan-based pharmaceutical manufacturer with a branded generics portfolio spanning cardiovascular, anti-infectives, and women's health — directly comparable to Efroze in domestic positioning and therapeutic mix.
- Pharm-Evo: Pharm-Evo is a Pakistani pharmaceutical company producing branded generics across therapeutic segments with strong domestic distribution and growing international presence — directly comparable to Efroze's business model and product breadth.
- Getz Pharma: Getz Pharma is one of the largest Pakistani pharmaceutical manufacturers with a broad branded generics portfolio spanning multiple therapeutic areas including cardiology, gynecology, and anti-infectives — directly comparable to Efroze in product breadth, distribution model, and export orientation.
- Nabi Qasim Industries: Nabi Qasim Industries is a Pakistani pharmaceutical manufacturer producing branded generics across multiple therapeutic segments with both domestic and export operations — comparable to Efroze in scale, product diversification, and export orientation.
- Sami Pharmaceuticals: Sami Pharmaceuticals is a Pakistan-based pharmaceutical manufacturer with a branded generics portfolio across cardiovascular, anti-diabetic, and other therapeutic areas — directly comparable to Efroze in product mix and channel strategy.
Broad incumbents
- Abbott Pakistan: Abbott Pakistan is a multinational pharmaceutical incumbent with broad therapeutic coverage across Pakistan including primary care and women's health — comparable as a much larger incumbent competing in many of the same therapeutic categories as Efroze.
- GSK Pakistan: GSK Pakistan is a multinational pharmaceutical incumbent with a broad branded portfolio across multiple therapeutic areas including respiratory and anti-infectives — comparable to Efroze as a larger incumbent competitor in overlapping therapeutic segments.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Efroze Chemical Industries social profiles
Digital presenceEfroze Chemical Industries compliance and trust
Trust signalCompliance4 records
Efroze Chemical Industries financial estimates
Financial estimateRevenue estimate
Valuation estimate
Efroze Chemical Industries leadership team
Management profileNumber of profiles
Profiles5 records
Efroze Chemical Industries subsidiaries and ownership
Company hierarchySubsidiaries2 records
Efroze Chemical Industries funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Efroze Chemical Industries M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Efroze Chemical Industries
What does Efroze Chemical Industries do?
Efroze Chemical Industries manufactures and markets a diversified portfolio of over 40 branded pharmaceutical products in solid and liquid dosage forms (tablets, capsules, syrups, suspensions, dry powders, and specialty hormone products). The company's product range spans cardiology, orthopedics/pain management, gynecology, gastroenterology, anti-infectives, respiratory, anti-diabetic, and anti-malarial therapeutic categories, sold domestically through 70+ distributors covering 40,000+ pharmacies in Pakistan and exported to 22+ countries worldwide.
Is Efroze Chemical Industries a public or private company?
Efroze Chemical Industries is a private company. It is classified as family owned and is currently operating.
When was Efroze Chemical Industries founded?
Efroze Chemical Industries was founded in 1968. It employs 501 to 1,000 people.
Where is Efroze Chemical Industries based?
Efroze Chemical Industries is headquartered in Karachi, Pakistan, in the Asia region.
How does Efroze Chemical Industries make money?
Two revenue lines are on record. Pharmaceutical Product Sales are the primary driver. The others are international Exports.
Who are Efroze Chemical Industries's main competitors?
Direct peers on record are Ferozsons Laboratories, Hilton Pharma, Searle Pakistan, Barrett Hodgson Pakistan, Pharm-Evo, Getz Pharma, Nabi Qasim Industries and Sami Pharmaceuticals. Broad incumbents are Abbott Pakistan and GSK Pakistan.
Does Efroze Chemical Industries have an API?
No public API is recorded for Efroze Chemical Industries.
What industry is Efroze Chemical Industries in?
Efroze Chemical Industries's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIAAAJ, Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health). Its NAICS code is 32541 and its SIC code is 2834.